DEVICE CATEGORY · NPT
Aortic Valve, Prosthesis, Percutaneously Delivered
To replace a patient's aortic heart valve. They are different from the classified device (heart valves) in that they are placed percutaneously and do not require open chest surgery or a cardiotomy for placement.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA supplement | Nov 7, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 29, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 22, 2026 | FDA | |
Trilogy Transcatheter Heart Valve SystemP250024/S005 | JenaValve Technology, Inc. | PMA supplement | Oct 13, 2026 | FDA |
Trilogy Transcatheter Heart Valve SystemP250024/S006 | JenaValve Technology, Inc. | PMA supplement | Oct 7, 2026 | FDA |
| Edwards Lifesciences, LLC | PMA supplement | Sep 23, 2026 | FDA | |
| JenaValve Technology, Inc. | PMA approval | Mar 17, 2026 | FDA | |
| ABBOTT MEDICAL | PMA approval | Sep 17, 2021 | FDA | |
| Edwards Lifesciences, LLC | PMA approval | Jun 17, 2015 | FDA | |
MEDTRONIC COREVALVE SYSTEMP130021 | Medtronic, Inc. | PMA approval | Jan 17, 2014 | FDA |
Source information
Follow the FDA links to view the original records.

